世界の低分子干渉RNA（siRNA）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4874 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、低分子干渉RNA（siRNA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リポソームベース全身療法、ナノ粒子ベース全身療法、その他）、用途別市場規模（病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・低分子干渉RNA（siRNA）治療薬の市場動向 ・企業の競争状況、市場シェア ・低分子干渉RNA（siRNA）治療薬の種類別市場規模と予測2016-2027（リポソームベース全身療法、ナノ粒子ベース全身療法、その他） ・低分子干渉RNA（siRNA）治療薬の用途別市場規模と予測2016-2027（病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他） ・低分子干渉RNA（siRNA）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・低分子干渉RNA（siRNA）治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・低分子干渉RNA（siRNA）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・低分子干渉RNA（siRNA）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・低分子干渉RNA（siRNA）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GE、Horizon Discovery、Thermo Scientific、OPKO Health、AInylam Pharmaceuticals、Arrowhead Research、Sanofi Genzyme、Genecon Biotechnologies、Arbutus Biopharma、Silent Therapeutics、Sylentis） ・結論

Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It’s also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell’s own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.

Market Analysis and Insights: Global Small Interfering RNA (siRNA) Therapeutics Market
The global Small Interfering RNA (siRNA) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Small Interfering RNA (siRNA) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Small Interfering RNA (siRNA) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Small Interfering RNA (siRNA) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Small Interfering RNA (siRNA) Therapeutics market.

Global Small Interfering RNA (siRNA) Therapeutics Scope and Market Size
Small Interfering RNA (siRNA) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Interfering RNA (siRNA) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other

Segment by Application
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposome Based Systemic Therapy
1.2.3 Nanoparticle Based Systemic Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Perspective (2016-2027)
2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Small Interfering RNA (siRNA) Therapeutics Industry Dynamic
2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Trends
2.3.2 Small Interfering RNA (siRNA) Therapeutics Market Drivers
2.3.3 Small Interfering RNA (siRNA) Therapeutics Market Challenges
2.3.4 Small Interfering RNA (siRNA) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue
3.1.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
3.4 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio
3.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2020
3.5 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
3.6 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
3.7 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Type
4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Application
5.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
6.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
6.2.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
6.3.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
6.4.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type
7.2.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application
7.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
7.4.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
9.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
9.2.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
9.3.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
9.4.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GE
11.1.1 GE Company Details
11.1.2 GE Business Overview
11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
11.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.1.5 GE Recent Development
11.2 Horizon Discovery
11.2.1 Horizon Discovery Company Details
11.2.2 Horizon Discovery Business Overview
11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
11.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.2.5 Horizon Discovery Recent Development
11.3 Thermo Scientific
11.3.1 Thermo Scientific Company Details
11.3.2 Thermo Scientific Business Overview
11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
11.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.3.5 Thermo Scientific Recent Development
11.4 OPKO Health
11.4.1 OPKO Health Company Details
11.4.2 OPKO Health Business Overview
11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
11.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.4.5 OPKO Health Recent Development
11.5 AInylam Pharmaceuticals
11.5.1 AInylam Pharmaceuticals Company Details
11.5.2 AInylam Pharmaceuticals Business Overview
11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
11.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.5.5 AInylam Pharmaceuticals Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Details
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
11.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.6.5 Arrowhead Research Recent Development
11.7 Sanofi Genzyme
11.7.1 Sanofi Genzyme Company Details
11.7.2 Sanofi Genzyme Business Overview
11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
11.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.7.5 Sanofi Genzyme Recent Development
11.8 Genecon Biotechnologies
11.8.1 Genecon Biotechnologies Company Details
11.8.2 Genecon Biotechnologies Business Overview
11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
11.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.8.5 Genecon Biotechnologies Recent Development
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Details
11.9.2 Arbutus Biopharma Business Overview
11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
11.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.9.5 Arbutus Biopharma Recent Development
11.10 Silent Therapeutics
11.10.1 Silent Therapeutics Company Details
11.10.2 Silent Therapeutics Business Overview
11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
11.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.10.5 Silent Therapeutics Recent Development
11.11 Sylentis
11.11.1 Sylentis Company Details
11.11.2 Sylentis Business Overview
11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
11.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
11.11.5 Sylentis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liposome Based Systemic Therapy
Table 3. Key Players of Nanoparticle Based Systemic Therapy
Table 4. Key Players of Other
Table 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2022-2027)
Table 11. Small Interfering RNA (siRNA) Therapeutics Market Trends
Table 12. Small Interfering RNA (siRNA) Therapeutics Market Drivers
Table 13. Small Interfering RNA (siRNA) Therapeutics Market Challenges
Table 14. Small Interfering RNA (siRNA) Therapeutics Market Restraints
Table 15. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2020)
Table 18. Ranking of Global Top Small Interfering RNA (siRNA) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
Table 22. Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GE Company Details
Table 63. GE Business Overview
Table 64. GE Small Interfering RNA (siRNA) Therapeutics Product
Table 65. GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GE Recent Development
Table 67. Horizon Discovery Company Details
Table 68. Horizon Discovery Business Overview
Table 69. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product
Table 70. Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Horizon Discovery Recent Development
Table 72. Thermo Scientific Company Details
Table 73. Thermo Scientific Business Overview
Table 74. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product
Table 75. Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Thermo Scientific Recent Development
Table 77. OPKO Health Company Details
Table 78. OPKO Health Business Overview
Table 79. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product
Table 80. OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 81. OPKO Health Recent Development
Table 82. AInylam Pharmaceuticals Company Details
Table 83. AInylam Pharmaceuticals Business Overview
Table 84. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product
Table 85. AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 86. AInylam Pharmaceuticals Recent Development
Table 87. Arrowhead Research Company Details
Table 88. Arrowhead Research Business Overview
Table 89. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product
Table 90. Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Arrowhead Research Recent Development
Table 92. Sanofi Genzyme Company Details
Table 93. Sanofi Genzyme Business Overview
Table 94. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product
Table 95. Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Sanofi Genzyme Recent Development
Table 97. Genecon Biotechnologies Company Details
Table 98. Genecon Biotechnologies Business Overview
Table 99. Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Genecon Biotechnologies Recent Development
Table 101. Arbutus Biopharma Company Details
Table 102. Arbutus Biopharma Business Overview
Table 103. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product
Table 104. Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Arbutus Biopharma Recent Development
Table 106. Silent Therapeutics Company Details
Table 107. Silent Therapeutics Business Overview
Table 108. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product
Table 109. Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Silent Therapeutics Recent Development
Table 111. Sylentis Company Details
Table 112. Sylentis Business Overview
Table 113. Sylentis Small Interfering RNA (siRNA) Therapeutics Product
Table 114. Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Sylentis Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Liposome Based Systemic Therapy Features
Figure 3. Nanoparticle Based Systemic Therapy Features
Figure 4. Other Features
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Academic Institutions Case Studies
Figure 10. Other Case Studies
Figure 11. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players in 2020
Figure 17. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2020
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Region (2016-2027)
Figure 41. China Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GE Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 61. Horizon Discovery Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 62. Thermo Scientific Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 63. OPKO Health Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 64. AInylam Pharmaceuticals Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 65. Arrowhead Research Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 66. Sanofi Genzyme Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 67. Genecon Biotechnologies Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 68. Arbutus Biopharma Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 69. Silent Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 70. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---